Neurovalens has developed a headset (Modius) which indirectly stimulates the hypothalamus triggering the body to burn fat and reduce appetite. Pilot studies have confirmed the efficacy of the headset and the FDA has authorised it's sale in the USA market as a wellness device. The investment round will provide funds to launch the product via the Indiegogo platform and conduct a larger medical device trial.